Waters Corporation
Financials
Valuation Metrics
Waters Corporation's Market Cap is $42.22B. At end of 2025 it was $22.62B. Ranked #362 of 3,121 in US market (top 12%), #261 of 1,658 on NYSE (top 16%), #23 of 205 in Health Care Equipment & Services (top 11%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $42.22B | US#362/3,121 Sec#23/205 |
| Revenue | $4.64B | US#932/3,121 Sec#53/205 |
| Net Income | $166M | US#1,386/3,121 Sec#67/205 |
| Total Assets | $24.75B | US#542/3,121 Sec#25/205 |
| Net Assets | $15.20B | US#294/3,121 Sec#17/205 |
| Employees | 7,900 | US#985/3,121 Sec#74/205 |
| Value | ||
| P/E | 254.12x | US#2,192/3,121 Sec#113/205 |
| P/B | 2.78x | US#1,656/3,121 Sec#87/205 |
| P/S | 9.09x | US#2,659/3,121 Sec#180/205 |
| EV/EBITDA | 52.39x | US#2,372/3,121 Sec#128/205 |
| FCF Yield | 0.94% | US#2,191/3,121 Sec#132/205 |
| Profitability | ||
| ROE | 1.09% | US#2,088/3,121 Sec#110/205 |
| ROA | 0.67% | US#2,095/3,121 Sec#117/205 |
| Op. Margin | 7.96% | US#1,767/3,121 Sec#93/205 |
| Revenue Growth | 52.47% | US#215/3,121 Sec#10/205 |
| Earnings Growth | -74.88% | US#1,829/3,121 Sec#96/205 |
| Financial Health | ||
| Debt Ratio | 62.89% | US#694/3,121 Sec#76/205 |
| Total Debt | $5.25B | US#663/3,121 Sec#33/205 |
| FCF | $398M | US#996/3,121 Sec#57/205 |
| Cash | $539M | US#1,027/3,121 Sec#55/205 |
| Current Ratio | 1.86x | US#1,337/3,121 Sec#114/205 |
| Net Debt/EBITDA | 5.26x | US#2,058/3,121 Sec#129/205 |
| Performance | ||
| 1Y Return | 41.59% | US#690/3,121 Sec#60/205 |
| 1M Return | 7.16% | US#345/3,121 Sec#47/205 |
| From 52W High | -0.41% | US#22/3,121 Sec#5/205 |
| 1Y MDD | -31.32% | US#1,515/3,121 Sec#70/205 |
| Trading | ||
| Volume | 522,614 shares | US#1,980/3,121 Sec#140/205 |
| Trading Value | $224M | US#418/3,121 Sec#36/205 |
| Per Share | ||
| EPS | $1.69 | US#1,439/3,121 Sec#74/205 |
| BPS | $154.76 | US#38/3,121 Sec#5/205 |
Company Info
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.